logo
welcome
Benzinga

Benzinga

Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED)

Benzinga
Summary
Nutrition label

80% Informative

Centers for Medicare & Medicaid Services posted final payment determinations for its 2025 Clinical Laboratory Fee Schedule.

William Blair writes that the determinations effectively raise reimbursement by 16% versus the current Medicare rate for the first -generation Cologuard test.

The determination reverses the September preliminary decision but aligns with a proposal made during the public comment period.

Exact Sciences stock is up 7.60% at $ 59.33 at last check Tuesday .

VR Score

81

Informative language

83

Neutral language

6

Article tone

formal

Language

English

Language complexity

46

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

12

https://www.benzinga.com/stock/EXAS/ratings?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=42195803https://www.benzinga.com/calendar/ratings?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=42195803https://www.benzinga.com/24/11/42190381/analog-devices-q4-earnings-beats-estimates-automotive-rebound-outlook?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=42195803https://www.benzinga.com/general/health-care/24/11/42195803/why-is-exact-sciences-stock-trading-higher-on-mondayhttps://www.benzinga.comhttps://www.benzinga.com/pressreleases/24/11/b42177702/exact-sciences-advances-breast-cancer-care-with-the-oncotype-dx-test-and-genomic-profiling-researc?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=42195803https://www.benzinga.com/news/large-cap/24/10/41185292/fda-clears-exact-sciences-next-generation-colorectal-cancer-diagnostic-test?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=42195803https://www.benzinga.com/quote/EXAS?getReport=1https://www.benzinga.com/quote/EXAS/analyst-ratings?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=42195803https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41776963/colorectal-cancer-diagnostic-focused-exact-sciences-stock-plunges-on-weak-annual-gu?utm_campaign=partner_feed&utm_source=yahooFinance&utm_medium=partner_feed&utm_content=site&nid=42195803https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9spja3yaad2&utm_source=yahoohttps://www.cms.gov/medicare/payment/fee-schedules/clinical-laboratory-fee-schedule-clfs/annual-public-meetings

Affiliate links

no affiliate links